- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Apr 29, 2026 | 95.04M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 95.69M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 93.81M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 91.18M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 91.31M sh |
| Stock Repurchased | Q2 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q2 2026 · Mar 31, 2025 | $50.47M |
| Dividends Paid | Q2 2026 · Mar 31, 2026 | $99.19M |
| Dividends Paid | Q2 2026 · Mar 31, 2025 | $93.54M |
| Capex | Q2 2026 · Mar 31, 2026 | $498.27M |
| Capex | Q2 2026 · Mar 31, 2025 | $434.26M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | $657.28M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | $473.87M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $2.08B |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $2.38B |
| Short Term Debt | Q2 2026 · Mar 31, 2026 | $41.3M |
| Short Term Debt | Q2 2026 · Sep 30, 2025 | $150.2M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $26.6M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $43.17M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $39.95M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2024 | $38.22M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $820.15M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $925.76M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $507.6M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $410.73M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $9.13B |
| Total Assets | Q2 2026 · Sep 30, 2025 | $8.72B |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $2.59 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $4.58 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $2.37 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $2.86 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $2.61 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $4.61 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $2.39 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $2.88 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $18.41M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $37.75M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $18.79M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $38.06M |
| Net Income | Q2 2026 · Mar 31, 2026 | $247.67M |
| Net Income | Q2 2026 · Mar 31, 2026 | $429.31M |
| Net Income | Q2 2026 · Mar 31, 2025 | $216.36M |
| Net Income | Q2 2026 · Mar 31, 2025 | $261.34M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $347.14M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $623.26M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $317.25M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $403.44M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $207.85M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $293.46M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $135.34M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $200.68M |
| Revenue | Q2 2026 · Mar 31, 2026 | $909.03M |
| Revenue | Q2 2026 · Mar 31, 2026 | $1.55B |
| Revenue | Q2 2026 · Mar 31, 2025 | $734.76M |
| Revenue | Q2 2026 · Mar 31, 2025 | $1.25B |